Роль нейропилина-1 (NRP1) в развитии инфекции SARS-CoV-2
https://doi.org/10.25789/YMJ.2022.80.26
Аннотация
Представлен обзор литературы о роли нейропилина-1 в развитии инфекции SARS-CoV-2 и поиск вероятных связей полиморфных вариантов гена NRP1 c SARS-CoV-2. В данном обзоре приведены характеристики полиморфных вариантов гена NRP1, которые демонстрируют возможность их связи с течением инфекции SARS-CoV-2.
При поддержке: Работа выполнена при финансовой поддержке программы стратегического академического лидерства «Приоритет 2030».
Об авторах
В. А. Маркелов
ФГБОУ ВО БашГУ;
ФГБОУ ВО БГМУ Минздрава России
Россия
Россия
Маркелов Виталий Андреевич – магистрант ФГБОУ ВО БашГУ; ст. лаборант ФГБОУ ВО БГМУ
К. В. Данилко
ФГБОУ ВО БГМУ Минздрава России
Россия
Россия
Данилко Ксения Владимировна – к.б.н., доцент ФГБОУ ВО БГМУ Минздрава России, с.н.с. ЦНИЛ ФГБОУ ВО БГМУ
Список литературы
1. Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N Engl J Med. 2020 Jul 9; 383(2):120-128. doi: 10.1056/NEJMoa2015432.
2. Alnomasy SF. Virus-receptor interactions of SARS-CoV-2 spike receptor-binding domain and human neuropilin-1 b1 domain. Saudi J Biol Sci. 2021 Jul; 28(7):3926-3928. doi: 10.1016/j.sjbs.2021.03.074.
3. Burks SM, Rosas-Hernandez H, Alejandro Ramirez-Lee M, et al. Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier? Brain Behav Immun. 2021 Jul;95:7-14. doi: 10.1016/j.bbi.2020.12.031.
4. Buzhdygan TP, DeOre BJ, Baldwin-Leclair A, et al. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier. Neurobiol Dis. 2020 Dec;146:105131. doi: 10.1016/j.nbd.2020.105131.
5. Bruder D, Probst-Kepper M, Westendorf AM, et al. Neuropilin-1: a surface marker of regulatory T cells. Eur J Immunol. 2004 Mar;34(3):623-630. doi: 10.1002/eji.200324799.
6. Cantuti-Castelvetri L, Ojha R, Pedro LD, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020 Nov 13;370(6518):856-860. doi: 10.1126/science.abd2985.
7. Daly JL, Simonetti B, Klein K, et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science. 2020 Nov 13;370(6518):861865. doi: 10.1126/science.abd3072.
8. Duran I, Tenney J, Warren CM, et al. NRP1 haploinsufficiency predisposes to the development of Tetralogy of Fallot. Am J Med Genet A. 2018 Mar;176(3):649-656. doi: 10.1002/ajmg.a.38600.
9. Girija ASS. Fox3+ CD25+ CD4+ T-regulatory cells may transform the nCoV's final destiny to CNS! J Med Virol. 2021 Oct;93(10):5673-5675. doi: 10.1002/jmv.26482.
10. Gerger A, El-Khoueiry A, Zhang W, et al. Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Clin Cancer Res. 2011 Sep 1;17(17):5783-92. doi: 10.1158/1078-0432.CCR11-1115.
11. Grage-Griebenow E, Löseke S, Kauth M, et al. Anti-BDCA-4 (neuropilin-1) antibody can suppress virus-induced IFN-alpha production of plasmacytoid dendritic cells. Immunol Cell Biol. 2007 Jul;85(5):383-90. doi: 10.1038/sj.icb.7100048.
12. Guo HF, Vander Kooi CW. Neuropilin Functions as an Essential Cell Surface Receptor. J Biol Chem. 2015 Dec 4; 290(49):29120-6. doi: 10.1074/jbc.R115.687327.
13. Hopkins C, Lechien JR, Saussez S. More than ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival. Med Hypotheses. 2021 Jan;146:110406. doi: 10.1016/j.mehy.2020.110406.
14. Hamming I, Timens W, Bulthuis ML, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004 Jun;203(2):631-7. doi: 10.1002/path.1570.
15. Hippensteel JA, LaRiviere WB, Colbert JF, et al. Heparin as a therapy for COVID-19: current evidence and future possibilities. Am J Physiol Lung Cell Mol Physiol. 2020 Aug 1;319(2):L211-L217. doi: 10.1152/ajplung.00199.2020.
16. Hashemi SMA, Thijssen M, Hosseini SY, et al. Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection. Arch Virol. 2021 Aug;166(8):2089-2108. doi: 10.1007/s00705021-05070-6.
17. Hancock JT, Rouse RC, Stone E, Greenhough A. Interacting Proteins, Polymorphisms and the Susceptibility of Animals to SARS-CoV-2. Animals (Basel). 2021 Mar 12;11(3):797. doi: 10.3390/ani11030797.
18. Jobe A, Vijayan R. Characterization of peptide binding to the SARS-CoV-2 host factor neuropilin. Heliyon. 2021 Oct;7(10):e08251. doi: 10.1016/j.heliyon.2021.e08251.
19. Kirschenbaum D, Imbach LL, Ulrich S, et al. Inflammatory olfactory neuropathy in two patients with COVID-19. Lancet. 2020 Jul 18;396(10245):166. doi: 10.1016/S01406736(20)31525-7.
20. Klaewkla M, Charoenwongpaiboon T, Mahalapbutr P. Molecular basis of the new COVID-19 target neuropilin-1 in complex with SARS-CoV-2 S1 C-end rule peptide and small-molecule antagonists. J Mol Liq. 2021 Aug 1;335:116537. doi: 10.1016/j.molliq.2021.116537.
21. Li ZL, Buck M. Neuropilin-1 assists SARSCoV-2 infection by stimulating the separation of spike protein domains S1 and S2. bioRxiv [Preprint]. 2021 Jan 19:2021.01.06.425627. doi: 10.1101/2021.01.06.425627. Update in: Biophys J. 2021 Jul 20;120(14):2828-2837.
22. Lyu Z, Jin H, Yan Z, et al. Effects of NRP1 on angiogenesis and vascular maturity in endothelial cells are dependent on the expression of SEMA4D. Int J Mol Med. 2020 Oct;46(4):13211334. doi: 10.3892/ijmm.2020.4692.
23. Lorés-Motta L, van Asten F, Muether PS, et al. A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration. Pharmacogenet Genomics. 2016 Jan;26(1):207. doi: 10.1097/FPC.0000000000000180.
24. Moutal A, Martin LF, Boinon L, et al. SARS-CoV-2 spike protein co-opts VEGF-A/ neuropilin-1 receptor signaling to induce analgesia. Pain. 2021 Jan;162(1):243-252. doi: 10.1097/j.pain.0000000000002097.
25. Mayi BS, Leibowitz JA, Woods AT, et al. The role of Neuropilin-1 in COVID-19. PLoS Pathog. 2021 Jan 4;17(1):e1009153. doi: 10.1371/journal.ppat.1009153.
26. Men M, Chen DN, Li JD, et al. Analysis of PLXNA1, NRP1, and NRP2 variants in a cohort of patients with isolated hypogonadotropic hypogonadism. Mol Genet Genomic Med. 2021 Nov;9(11):e1816. doi: 10.1002/mgg3.1816.
27. Nakamura F, Tanaka M, et al. Neuropilin-1 extracellular domains mediate semaphorin D/ III-induced growth cone collapse. Neuron. 1998 Nov;21(5):1093-100. doi: 10.1016/s08966273(00)80626-1.
28. Parker MW, Xu P, Li X, Vander Kooi CW. Structural basis for selective vascular endothelial growth factor-A (VEGF-A) binding to neuropilin-1. J Biol Chem. 2012 Mar 30;287(14):11082-9. doi: 10.1074/jbc.M111.331140.
29. Pollock CE, Sutherland HG, Maher BH, et al. The NRP1 migraine risk variant shows evidence of association with menstrual migraine. J Headache Pain. 2018 Apr 18;19(1):31. doi: 10.1186/s10194-018-0857-z.
30. Pellet-Many C, Frankel P, et al. Neuropilins: structure, function and role in disease. Biochem J. 2008 Apr 15;411(2):211-26. doi: 10.1042/BJ20071639.
31. Siri M, Dastghaib S, Zamani M, et al. Autophagy, unfolded protein response, and neuropilin-1 cross-talk in SARS-CoV-2 infection: what can be learned from other coronaviruses. Int J Mol Sci. 2021 Jun 1;22(11):5992. doi: 10.3390/ijms22115992.
32. Sun B, Wu XY, Nie M. [SARS-CoV-2 damages male fertility: How and why]. Zhonghua Nan Ke Xue. 2021 Aug;27(8):738-741. Chinese. PMID: 34914248.
33. Vander Kooi CW, Jusino MA, Perman B, et al. Structural basis for ligand and heparin binding to neuropilin B domains. Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6152-7. doi: 10.1073/pnas.0700043104.
34. Xu J, Qi L, Chi X, et al. Orchitis: a complicationofsevereacuterespiratorysyndrome (SARS). Biol Reprod. 2006 Feb;74(2):410-6. doi: 10.1095/biolreprod.105.044776.
35. Zhao Y, Zhu R, Xiao T, Liu X. Genetic variants in migraine: a field synopsis and systematic re-analysis of meta-analyses. J Headache Pain. 2020 Feb 11;21(1):13. doi: 10.1186/s10194-020-01087-5.
Рецензия
Для цитирования:
Маркелов В.А., Данилко К.В. Роль нейропилина-1 (NRP1) в развитии инфекции SARS-CoV-2. Якутский медицинский журнал. 2022;(4):101-103. https://doi.org/10.25789/YMJ.2022.80.26
For citation:
Markelov V.A., Danilko A.V. The role of neuropilin-1 (NRP1) in the development of SARS-CoV-2 infection. Yakut Medical Journal. 2022;(4):101-103. https://doi.org/10.25789/YMJ.2022.80.26
Просмотров:
30
Послать статью по эл. почте 